785 related articles for article (PubMed ID: 29173113)
1. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
2. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature.
Deguchi S; Mitsuya K; Nakasu Y; Hayashi N; Katagiri H; Murata H; Wasa J; Takahashi M; Endo M
Invest New Drugs; 2018 Apr; 36(2):346-349. PubMed ID: 29067537
[TBL] [Abstract][Full Text] [Related]
3. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
Tetsuka S; Nonaka H
BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
[TBL] [Abstract][Full Text] [Related]
4. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
[TBL] [Abstract][Full Text] [Related]
5. Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.
Gil I; Serrazina F; Pinto M; Viana-Baptista M
BMJ Case Rep; 2020 Feb; 13(2):. PubMed ID: 32066575
[TBL] [Abstract][Full Text] [Related]
6. Generalised reversible encephalopathy syndrome: a variant of posterior reversible encephalopathy syndrome (PRES).
Kunzmann J; Wolf H; Oberndorfer S
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26611477
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.
How J; Blattner M; Fowler S; Wang-Gillam A; Schindler SE
Neurologist; 2016 Nov; 21(6):112-117. PubMed ID: 27801773
[TBL] [Abstract][Full Text] [Related]
8. A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin.
Cherniawsky H; Merchant N; Sawyer M; Ho M
Medicine (Baltimore); 2017 Feb; 96(8):e5850. PubMed ID: 28225482
[TBL] [Abstract][Full Text] [Related]
9. A Case of Posterior Reversible Encephalopathy Syndrome Induced by Cisplatin/Pemetrexed Chemotherapy for Lung Cancer.
Ishihara M; Matsutani N; Ota S; Seki N
Case Rep Oncol; 2017; 10(1):235-238. PubMed ID: 28611637
[TBL] [Abstract][Full Text] [Related]
10. Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review.
Xie C; Jones VT
Oncol Lett; 2016 Feb; 11(2):1512-1516. PubMed ID: 26893771
[TBL] [Abstract][Full Text] [Related]
11. Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.
Kamiya-Matsuoka C; Paker AM; Chi L; Youssef A; Tummala S; Loghin ME
J Neurooncol; 2016 May; 128(1):75-84. PubMed ID: 26900076
[TBL] [Abstract][Full Text] [Related]
12. Posterior reversible encephalopathy syndrome following a scorpion sting.
Porcello Marrone LC; Marrone BF; Neto FK; Costa FC; Thomé GG; Aramburu MB; Schilling LP; Pascoal TA; Gadonski G; Huf Marrone AC; da Costa JC
J Neuroimaging; 2013 Oct; 23(4):535-6. PubMed ID: 23551823
[TBL] [Abstract][Full Text] [Related]
13. Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal.
Agarwal A; Kapur G; Altinok D
Neuroradiol J; 2015 Dec; 28(6):638-43. PubMed ID: 26515749
[TBL] [Abstract][Full Text] [Related]
14. Posterior reversible encephalopathy syndrome following elevated mean arterial pressures for cervical spinal cord injury.
Zimering JH; Mesfin A
J Spinal Cord Med; 2018 Jan; 41(1):111-114. PubMed ID: 27917700
[TBL] [Abstract][Full Text] [Related]
15. [Posterior Reversible Encephalopathy Syndrome (PRES): About 4 cases].
Chanal E; Bouleftour W; Rivoirard R; Bosaki C; Forges F; Jacquin JP; Fournel P; Mery B; Saban-Roche L
Presse Med; 2019 Oct; 48(10):1026-1031. PubMed ID: 31653541
[No Abstract] [Full Text] [Related]
16. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Anaplastic Thyroid Carcinoma.
Osawa Y; Gozawa R; Koyama K; Nakayama T; Sagoh T; Sunaga H
Intern Med; 2018 Apr; 57(7):1015-1019. PubMed ID: 29225265
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-related posterior reversible leukoencephalopathy syndrome.
Bhatt A; Farooq MU; Majid A; Kassab M
Nat Clin Pract Neurol; 2009 Mar; 5(3):163-9. PubMed ID: 19262592
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological findings from an autopsied case showing posterior reversible encephalopathy syndrome-like neuroradiological findings associated with premedication including tacrolimus for autologous peripheral blood stem cell transplantation.
Hayashi Y; Kimura A; Nakamura H; Mimuro M; Iwasaki Y; Hara A; Yoshida M; Inuzuka T
J Neurol Sci; 2017 Apr; 375():382-387. PubMed ID: 28320172
[TBL] [Abstract][Full Text] [Related]
19. Extended use dexamethasone-associated posterior reversible encephalopathy syndrome with cisplatin-based chemotherapy.
Nguyen MT; Virk IY; Chew L; Villano JL
J Clin Neurosci; 2009 Dec; 16(12):1688-90. PubMed ID: 19800799
[TBL] [Abstract][Full Text] [Related]
20. Posterior Reversible Encephalopathy Syndrome Associated with Sorafenib and Successful Retreatment.
Laruelle M; Filleul B; Duprez T; Machiels JP
Urol Int; 2018; 100(3):357-360. PubMed ID: 26845702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
